Concerta 54 mg is an extended-release oral tablet formulation of methylphenidate hydrochloride, a central nervous system (CNS) stimulant indicated for the treatment of Attention-Deficit/Hyperactivity Disorder (ADHD). It utilizes an osmotic-controlled release oral delivery system (OROS®) designed to provide gradual medication release throughout the day.

Methylphenidate works by increasing levels of dopamine and norepinephrine in the brain, neurotransmitters associated with attention, focus, and impulse control. The extended-release mechanism supports sustained symptom management in children, adolescents, and adults diagnosed with ADHD, as prescribed by a qualified healthcare professional.

Concerta 54 mg is manufactured under regulated pharmaceutical standards to ensure consistent potency, stability, and quality. As a Schedule II controlled substance in many regions, it carries a risk of misuse and dependence and should be used strictly under medical supervision.

Key Features

• Extended-release methylphenidate formulation

• Designed for once-daily dosing

• Supports management of ADHD symptoms

• OROS® delivery system for controlled release

• Intended for regulated clinical use